Pfizer vaccine meets criteria for success, FDA says

Published



The Food and Drug Administration signaled Tuesday that it is likely to approve emergency use authorization for the Pfizer/BioNTech coronavirus vaccine.

In a detailed analysis released Tuesday morning, the FDA said that it could find “no specific safety concerns identified that would preclude issuance of an EUA.”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.